Camilla Appelgren is a partner at Mannheimer Swartling. Her main areas of practice are life sciences, corporate, M&A and finance. She has been involved in domestic and cross-border transactions within the life sciences sector and a number of other industries, and regularly provides advice to publicly traded and privately held Swedish and international clients. Camilla has vast experience within the areas of healthcare, pharmaceuticals, food and medical devices, and regularly advises clients in contract negotiations and regulatory matters. Camilla is also engaged as a speaker at seminars and conferences, and has written a number of articles within the life sciences area. Camilla is ranked by Chambers as a leading individual within life sciences law in Sweden.